Please try another search
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Patrick D. Walsh | 63 | 2018 | Independent Chairman |
Jeanne A. Thoma | 65 | 2020 | Independent Director |
Renee P. Tannenbaum | 72 | 2022 | Independent Director |
Thomas J. Haughey | 60 | 2018 | Independent Director |
Antonio R. Pera | 67 | 2020 | Independent Director |
Matthew J. Leonard | 57 | 2023 | Independent Director |
Muthusamy Shanmugam | 56 | 2021 | Head of R&D, COO of Novitium Operations & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review